Dan Peisert

President and Chief Executive Officer

Therapeutic Areas

Drug	Indication	Phase
INDOCIN Suppositories	Patent Ductus Arteriosus (PDA)	Approved
INDOCIN Oral	Rheumatoid Arthritis, Osteoarthritis, Gout	Approved
Otrexup	Rheumatoid Arthritis, Psoriasis	Approved
ROLVEDON	Chemotherapy-induced Neutropenia	Approved
SYMJEPI	Anaphylaxis	Approved
Pipeline Candidate	Undisclosed	Undisclosed